Ruxolitinib cream versus tacrolimus ointment

Ruxolitinib cream and tacrolimus ointment (Topical tacrolimus) are two drugs commonly used to treat skin diseases. Both can reduce inflammation and itching and reduce the spread of skin lesions, but they have different mechanisms of action and indications. The choice of which drug to use should be determined by the doctor based on the patient's specific situation. Doctors will consider the type and severity of the disease, the patient's age and other relevant factors to determine the most appropriate treatment plan.

Ruxolitinib cream is aJanus kinase inhibitor, mainly used to treat moderate to severe atopic dermatitis and non-segmental vitiligo. It reduces symptoms by inhibiting inflammatory responses and regulating immune function, and has good local tolerance. Tacrolimus ointment is a calcineurin inhibitor that can be used as a second-line treatment drug for the short-term and non-continuous treatment of moderate to severe atopic dermatitis. It is used for non-immune deficient adults and children who are ineffective or unsuitable for other topical treatments or are not suitable for alternative treatments. Only a lower concentration (0.03%) formulation is suitable for pediatric patients aged 2-15 years old, and its mechanism of action in atopic dermatitis is unclear.

The original drug of ruxolitinib cream has not yet been marketed in China, so it cannot be included in medical insurance. The price of ruxolitinib cream Original drug, specificationsinn 1.5%*60g, which is marketed overseas, is around RMB 20,000 per tube (the price may fluctuate due to the exchange rate), which is relatively expensive. The price of generic ruxolitinib cream marketed overseas is relatively cheap, and its pharmaceutical ingredients are basically the same as those of the original drug. The price of the specificationinn 1.5%*30g produced by a Bangladesh pharmaceutical factory is around 600 yuan per tube (the price may fluctuate due to exchange rate effects).